Clinical Trials

64Cu-LLP2A for Imaging Hematologic Malignancies

Thursday, January 2, 2025 12:00 AM

Conditions: Multiple Myeloma; Low-Grade Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Lymphoplasmacytic Lymphoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia Interventions: Drug: 64Cu-LLP2A; Device: PET/CT Sponsors: ...

Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Tuesday, December 31, 2024 12:00 AM

Conditions: Diabetes Mellitus, Type 1 Interventions: Behavioral: Ketogenic Diet; Behavioral: Standard Diet Sponsors: Washington University School of Medicine Recruiting

Parenting Intervention for Mothers With Substance Use Disorder

Tuesday, January 7, 2025 12:00 AM

Conditions: Substance Use Disorders; Children of Mothers With Substance Use Disorders Interventions: Behavioral: THRIVE Sponsors: Boston Medical Center; Washington University School of Medicine Recruiting

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

Wednesday, January 8, 2025 12:00 AM

Conditions: Lung Cancer; Oligometastatic Lung Tumor Interventions: Radiation: One fraction stereotactic body radiotherapy; Device: HyperSight; Device: Ethos Sponsors: Washington University School of Medicine; Varian Medical Systems Recruiting

Eggs for Gut Health

Monday, January 13, 2025 12:00 AM

Conditions: Moderate Acute Malnutrition; Stunting; Environmental Enteric Dysfunction; Severe Acute Malnutrition Interventions: Dietary Supplement: Whole egg powder; Dietary Supplement: Corn powder; Dietary Supplement: Supercereal Plus; ...

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Tuesday, January 7, 2025 12:00 AM

Conditions: Pediatric Brain Tumor; Recurrent Pediatric Brain Tumor; Pediatric Supratentorial Neoplasm Interventions: Biological: Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells; Procedure: ...

Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2)

Wednesday, January 8, 2025 12:00 AM

Conditions: Depression; Anxiety Interventions: Behavioral: Lumen Coached PST Intervention.; Behavioral: Human Coached PST Intervention.; Behavioral: Optional (delayed) Lumen Coached PST (Waitlist control). Sponsors: University of Illinois ...

Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma

Monday, December 30, 2024 12:00 AM

Conditions: Large B-cell Lymphoma; High-grade B-cell Lymphoma; Transformed B-Cell Lymphoma; Follicular Lymphoma Grade 3B Interventions: Drug: Mosunetuzumab; Drug: DHAX; Drug: ICE Sponsors: Washington University School of Medicine; Genentech, Inc. Recruiting